| Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ... Science 359 (6371), 97-103, 2018 | 4358 | 2018 |
| Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases J Lloyd-Price, C Arze, AN Ananthakrishnan, M Schirmer, J Avila-Pacheco, ... Nature 569 (7758), 655-662, 2019 | 2348 | 2019 |
| Temporal development of the gut microbiome in early childhood from the TEDDY study CJ Stewart, NJ Ajami, JL O’Brien, DS Hutchinson, DP Smith, MC Wong, ... Nature 562 (7728), 583-588, 2018 | 1806 | 2018 |
| Tumor microbiome diversity and composition influence pancreatic cancer outcomes E Riquelme, Y Zhang, L Zhang, M Montiel, M Zoltan, W Dong, P Quesada, ... Cell 178 (4), 795-806. e12, 2019 | 1214 | 2019 |
| Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring SA Buffington, GV Di Prisco, TA Auchtung, NJ Ajami, JF Petrosino, ... Cell 165 (7), 1762-1775, 2016 | 1188 | 2016 |
| Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients EN Baruch, I Youngster, G Ben-Betzalel, R Ortenberg, A Lahat, L Katz, ... Science 371 (6529), 602-609, 2021 | 1183 | 2021 |
| The gut mycobiome of the Human Microbiome Project healthy cohort AK Nash, TA Auchtung, MC Wong, DP Smith, JR Gesell, MC Ross, ... Microbiome 5, 1-13, 2017 | 861 | 2017 |
| The human gut microbiome in early-onset type 1 diabetes from the TEDDY study T Vatanen, EA Franzosa, R Schwager, S Tripathi, TD Arthur, K Vehik, ... Nature 562 (7728), 589-594, 2018 | 827 | 2018 |
| Wild mouse gut microbiota promotes host fitness and improves disease resistance SP Rosshart, BG Vassallo, D Angeletti, DS Hutchinson, AP Morgan, ... Cell 171 (5), 1015-1028. e13, 2017 | 788 | 2017 |
| Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response CN Spencer, JL McQuade, V Gopalakrishnan, JA McCulloch, M Vetizou, ... Science 374 (6575), 1632-1640, 2021 | 571 | 2021 |
| Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial T Cascone, WN William Jr, A Weissferdt, CH Leung, HY Lin, A Pataer, ... Nature medicine 27 (3), 504-514, 2021 | 530 | 2021 |
| Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis L Gogokhia, K Buhrke, R Bell, B Hoffman, DG Brown, C Hanke-Gogokhia, ... Cell host & microbe 25 (2), 285-299. e8, 2019 | 477 | 2019 |
| Alterations in the gut microbiota can elicit hypertension in rats S Adnan, JW Nelson, NJ Ajami, VR Venna, JF Petrosino, RM Bryan Jr, ... Physiological genomics 49 (2), 96-104, 2017 | 398 | 2017 |
| Age‐related changes in the gut microbiota influence systemic inflammation and stroke outcome MS Spychala, VR Venna, M Jandzinski, SJ Doran, DJ Durgan, ... Annals of neurology 84 (1), 23-36, 2018 | 389 | 2018 |
| Altered mucosal microbiome diversity and disease severity in Sjögren syndrome CS de Paiva, DB Jones, ME Stern, F Bian, QL Moore, S Corbiere, ... Scientific reports 6 (1), 23561, 2016 | 356 | 2016 |
| Gut microbiome associates with lifetime cardiovascular disease risk profile among bogalusa heart study participants TN Kelly, LA Bazzano, NJ Ajami, H He, J Zhao, JF Petrosino, A Correa, ... Circulation research 119 (8), 956-964, 2016 | 352 | 2016 |
| Role of the gut microbiome in obstructive sleep apnea–induced hypertension DJ Durgan, BP Ganesh, JL Cope, NJ Ajami, SC Phillips, JF Petrosino, ... Hypertension 67 (2), 469-474, 2016 | 345 | 2016 |
| Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response KH Antunes, JL Fachi, R de Paula, EF da Silva, LP Pral, AÁ Dos Santos, ... Nature communications 10 (1), 3273, 2019 | 328 | 2019 |
| Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade MC Andrews, CPM Duong, V Gopalakrishnan, V Iebba, WS Chen, ... Nature medicine 27 (8), 1432-1441, 2021 | 315 | 2021 |
| IgA-coated E. coli enriched in Crohn’s disease spondyloarthritis promote TH17-dependent inflammation M Viladomiu, C Kivolowitz, A Abdulhamid, B Dogan, D Victorio, ... Science translational medicine 9 (376), eaaf9655, 2017 | 292 | 2017 |
Joseph PetrosinoBaylor College of MedicineVerified email at bcm.edu
